Report cover image

Global Special Medical Purpose Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 193 Pages
SKU # APRC20278168

Description

Summary

According to APO Research, The global Special Medical Purpose Infant Formula market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Special Medical Purpose Infant Formula include Abbott, Nestle, Danone, Bayer, Real Food Blends, ProNourish, MeadJohnson, Kate Farms and Glanbia Nutritionals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Special Medical Purpose Infant Formula, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Special Medical Purpose Infant Formula, also provides the sales of main regions and countries. Of the upcoming market potential for Special Medical Purpose Infant Formula, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Special Medical Purpose Infant Formula sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Special Medical Purpose Infant Formula market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Special Medical Purpose Infant Formula sales, projected growth trends, production technology, application and end-user industry.

Special Medical Purpose Infant Formula Segment by Company

Abbott
Nestle
Danone
Bayer
Real Food Blends
ProNourish
MeadJohnson
Kate Farms
Glanbia Nutritionals
Fresenius Kabi
Cambrooke Therapeutics
Ajinomoto
Special Medical Purpose Infant Formula Segment by Type

Amino Acid Metabolism Disorders
Breast Milk Nutritional Supplements
Extended Hydrolysis of Milk Protein
Lactose-free or Low-lactose
Premature/low Birth Weight Infants
Other
Special Medical Purpose Infant Formula Segment by Application

Pediatrics
Neonatal Intensive Care
Other
Special Medical Purpose Infant Formula Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Special Medical Purpose Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Special Medical Purpose Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Special Medical Purpose Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Special Medical Purpose Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Special Medical Purpose Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Special Medical Purpose Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Special Medical Purpose Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Special Medical Purpose Infant Formula Market Size, 2020 VS 2024 VS 2031
1.3 Global Special Medical Purpose Infant Formula Market Size Estimates and Forecasts (2020-2031)
1.4 Global Special Medical Purpose Infant Formula Sales Estimates and Forecasts (2020-2031)
1.5 Global Special Medical Purpose Infant Formula Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Special Medical Purpose Infant Formula Market Dynamics
2.1 Special Medical Purpose Infant Formula Industry Trends
2.2 Special Medical Purpose Infant Formula Industry Drivers
2.3 Special Medical Purpose Infant Formula Industry Opportunities and Challenges
2.4 Special Medical Purpose Infant Formula Industry Restraints
3 Special Medical Purpose Infant Formula Market by Manufacturers
3.1 Global Special Medical Purpose Infant Formula Revenue by Manufacturers (2020-2025)
3.2 Global Special Medical Purpose Infant Formula Sales by Manufacturers (2020-2025)
3.3 Global Special Medical Purpose Infant Formula Average Sales Price by Manufacturers (2020-2025)
3.4 Global Special Medical Purpose Infant Formula Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Special Medical Purpose Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Special Medical Purpose Infant Formula Manufacturers, Product Type & Application
3.7 Global Special Medical Purpose Infant Formula Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Special Medical Purpose Infant Formula Market CR5 and HHI
3.8.2 Global Top 5 and 10 Special Medical Purpose Infant Formula Players Market Share by Revenue in 2024
3.8.3 2024 Special Medical Purpose Infant Formula Tier 1, Tier 2, and Tier 3
4 Special Medical Purpose Infant Formula Market by Type
4.1 Special Medical Purpose Infant Formula Type Introduction
4.1.1 Amino Acid Metabolism Disorders
4.1.2 Breast Milk Nutritional Supplements
4.1.3 Extended Hydrolysis of Milk Protein
4.1.4 Lactose-free or Low-lactose
4.1.5 Premature/low Birth Weight Infants
4.1.6 Other
4.2 Global Special Medical Purpose Infant Formula Sales by Type
4.2.1 Global Special Medical Purpose Infant Formula Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Special Medical Purpose Infant Formula Sales by Type (2020-2031)
4.2.3 Global Special Medical Purpose Infant Formula Sales Market Share by Type (2020-2031)
4.3 Global Special Medical Purpose Infant Formula Revenue by Type
4.3.1 Global Special Medical Purpose Infant Formula Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Special Medical Purpose Infant Formula Revenue by Type (2020-2031)
4.3.3 Global Special Medical Purpose Infant Formula Revenue Market Share by Type (2020-2031)
5 Special Medical Purpose Infant Formula Market by Application
5.1 Special Medical Purpose Infant Formula Application Introduction
5.1.1 Pediatrics
5.1.2 Neonatal Intensive Care
5.1.3 Other
5.2 Global Special Medical Purpose Infant Formula Sales by Application
5.2.1 Global Special Medical Purpose Infant Formula Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Special Medical Purpose Infant Formula Sales by Application (2020-2031)
5.2.3 Global Special Medical Purpose Infant Formula Sales Market Share by Application (2020-2031)
5.3 Global Special Medical Purpose Infant Formula Revenue by Application
5.3.1 Global Special Medical Purpose Infant Formula Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Special Medical Purpose Infant Formula Revenue by Application (2020-2031)
5.3.3 Global Special Medical Purpose Infant Formula Revenue Market Share by Application (2020-2031)
6 Global Special Medical Purpose Infant Formula Sales by Region
6.1 Global Special Medical Purpose Infant Formula Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Special Medical Purpose Infant Formula Sales by Region (2020-2031)
6.2.1 Global Special Medical Purpose Infant Formula Sales by Region (2020-2025)
6.2.2 Global Special Medical Purpose Infant Formula Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Special Medical Purpose Infant Formula Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Special Medical Purpose Infant Formula Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Special Medical Purpose Infant Formula Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Special Medical Purpose Infant Formula Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Special Medical Purpose Infant Formula Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Special Medical Purpose Infant Formula Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Special Medical Purpose Infant Formula Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Special Medical Purpose Infant Formula Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Special Medical Purpose Infant Formula Revenue by Region
7.1 Global Special Medical Purpose Infant Formula Revenue by Region
7.1.1 Global Special Medical Purpose Infant Formula Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Special Medical Purpose Infant Formula Revenue by Region (2020-2025)
7.1.3 Global Special Medical Purpose Infant Formula Revenue by Region (2026-2031)
7.1.4 Global Special Medical Purpose Infant Formula Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Special Medical Purpose Infant Formula Revenue (2020-2031)
7.2.2 North America Special Medical Purpose Infant Formula Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Special Medical Purpose Infant Formula Revenue (2020-2031)
7.3.2 Europe Special Medical Purpose Infant Formula Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Special Medical Purpose Infant Formula Revenue (2020-2031)
7.4.2 Asia-Pacific Special Medical Purpose Infant Formula Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Special Medical Purpose Infant Formula Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Special Medical Purpose Infant Formula Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Abbott
8.1.1 Abbott Comapny Information
8.1.2 Abbott Business Overview
8.1.3 Abbott Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Abbott Special Medical Purpose Infant Formula Product Portfolio
8.1.5 Abbott Recent Developments
8.2 Nestle
8.2.1 Nestle Comapny Information
8.2.2 Nestle Business Overview
8.2.3 Nestle Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Nestle Special Medical Purpose Infant Formula Product Portfolio
8.2.5 Nestle Recent Developments
8.3 Danone
8.3.1 Danone Comapny Information
8.3.2 Danone Business Overview
8.3.3 Danone Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Danone Special Medical Purpose Infant Formula Product Portfolio
8.3.5 Danone Recent Developments
8.4 Bayer
8.4.1 Bayer Comapny Information
8.4.2 Bayer Business Overview
8.4.3 Bayer Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Bayer Special Medical Purpose Infant Formula Product Portfolio
8.4.5 Bayer Recent Developments
8.5 Real Food Blends
8.5.1 Real Food Blends Comapny Information
8.5.2 Real Food Blends Business Overview
8.5.3 Real Food Blends Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Real Food Blends Special Medical Purpose Infant Formula Product Portfolio
8.5.5 Real Food Blends Recent Developments
8.6 ProNourish
8.6.1 ProNourish Comapny Information
8.6.2 ProNourish Business Overview
8.6.3 ProNourish Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 ProNourish Special Medical Purpose Infant Formula Product Portfolio
8.6.5 ProNourish Recent Developments
8.7 MeadJohnson
8.7.1 MeadJohnson Comapny Information
8.7.2 MeadJohnson Business Overview
8.7.3 MeadJohnson Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 MeadJohnson Special Medical Purpose Infant Formula Product Portfolio
8.7.5 MeadJohnson Recent Developments
8.8 Kate Farms
8.8.1 Kate Farms Comapny Information
8.8.2 Kate Farms Business Overview
8.8.3 Kate Farms Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Kate Farms Special Medical Purpose Infant Formula Product Portfolio
8.8.5 Kate Farms Recent Developments
8.9 Glanbia Nutritionals
8.9.1 Glanbia Nutritionals Comapny Information
8.9.2 Glanbia Nutritionals Business Overview
8.9.3 Glanbia Nutritionals Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Glanbia Nutritionals Special Medical Purpose Infant Formula Product Portfolio
8.9.5 Glanbia Nutritionals Recent Developments
8.10 Fresenius Kabi
8.10.1 Fresenius Kabi Comapny Information
8.10.2 Fresenius Kabi Business Overview
8.10.3 Fresenius Kabi Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Fresenius Kabi Special Medical Purpose Infant Formula Product Portfolio
8.10.5 Fresenius Kabi Recent Developments
8.11 Cambrooke Therapeutics
8.11.1 Cambrooke Therapeutics Comapny Information
8.11.2 Cambrooke Therapeutics Business Overview
8.11.3 Cambrooke Therapeutics Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Cambrooke Therapeutics Special Medical Purpose Infant Formula Product Portfolio
8.11.5 Cambrooke Therapeutics Recent Developments
8.12 Ajinomoto
8.12.1 Ajinomoto Comapny Information
8.12.2 Ajinomoto Business Overview
8.12.3 Ajinomoto Special Medical Purpose Infant Formula Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Ajinomoto Special Medical Purpose Infant Formula Product Portfolio
8.12.5 Ajinomoto Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Special Medical Purpose Infant Formula Value Chain Analysis
9.1.1 Special Medical Purpose Infant Formula Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Special Medical Purpose Infant Formula Production Mode & Process
9.2 Special Medical Purpose Infant Formula Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Special Medical Purpose Infant Formula Distributors
9.2.3 Special Medical Purpose Infant Formula Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.